Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure

被引:105
作者
Macaluso, M
Lawson, L
Akers, R
Valappil, T
Hammond, K
Blackwell, R
Hortin, G
机构
[1] Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[2] Univ Alabama, Sch Med, Dept Obstet & Gynecol, Birmingham, AL USA
[3] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL USA
关键词
barrier contraception; contraceptive efficacy; sexually transmitted diseases; phase II studies;
D O I
10.1016/S0010-7824(99)00013-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Forty women participated in three clinic visits during which they were exposed to their partner's semen (10 mu L, 100 mu L, and 1 ml). At each visit they took vaginal fluid samples before exposure to their partner's semen, immediately after, and at 1, 24, and 48 h after exposure. PSA was measured with an enzyme-linked immunoassay. The mean PSA level for preexposure swabs ranged between 0.43 and 0.88 ng/mL. The mean PSA levels were 193 immediately after exposure to 10 mu L, 472 after 100 mu L, and 19,098 after 1 ml. The PSA levels declined within 1 h, and returned to background at 48 h. The findings confirm that our procedure is a sensitive and specific method for detecting recent semen exposure, and indicate that PSA levels depend on exposure intensity and time since exposure. Application of this method in condom efficacy studies provides objective evidence of condom failure that enhances the interpretation of self-report. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 23 条
[1]   CONDOM USE AND BREAKAGE AMONG WOMEN IN A MUNICIPAL HOSPITAL FAMILY-PLANNING CLINIC [J].
ALBERT, AE ;
HATCHER, RA ;
GRAVES, W .
CONTRACEPTION, 1991, 43 (02) :167-176
[2]  
ARMBRUSTER DA, 1993, CLIN CHEM, V39, P181
[3]   PREVALENCE OF AIDS-RELATED RISK-FACTORS AND CONDOM USE IN THE UNITED-STATES [J].
CATANIA, JA ;
COATES, TJ ;
STALL, R ;
TURNER, H ;
PETERSON, J ;
HEARST, N ;
DOLCINI, MM ;
HUDES, E ;
GAGNON, J ;
WILEY, J ;
GROVES, R .
SCIENCE, 1992, 258 (5085) :1101-1106
[4]  
*CDC, 1988, MMWR-MORBID MORTAL W, V37, P133
[5]  
Diggle P., 2002, Analysis of Longitudinal Data
[6]  
DNISTRIAN AM, 1992, CLIN CHEM, V38, P2140
[7]   POSTCOITAL DETECTION OF A MALE-SPECIFIC SEMEN PROTEIN - APPLICATION TO THE INVESTIGATION OF RAPE [J].
GRAVES, HCB ;
SENSABAUGH, GF ;
BLAKE, ET .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (06) :338-343
[8]   DETECTION OF SEMEN IN CERVICOVAGINAL SECRETIONS [J].
HAIMOVICI, F ;
ANDERSON, DJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (03) :236-238
[9]   CHARACTERIZATION OF A MONOCLONAL-ANTIBODY TO A CONSERVED EPITOPE ON HUMAN SEMINAL VESICLE-SPECIFIC PEPTIDES - A NOVEL PROBE MARKER SYSTEM FOR SEMEN IDENTIFICATION [J].
HERR, JC ;
SUMMERS, TA ;
MCGEE, RS ;
SUTHERLAND, WM ;
SIGMAN, M ;
EVANS, RJ .
BIOLOGY OF REPRODUCTION, 1986, 35 (03) :773-784
[10]  
JOHNSON ED, 1993, J FORENSIC SCI, V38, P250